Skip to content

Jhunjhunwala#39;s RARE Trusts-backed Concord Biotech IPO booked 16% on debut

Concord Biotech IPO | Quadria Capital-backed Helix will be exiting the company by selling entire shareholding via IPO. Hence, the company will not get any money from the offer.

Read More

​ Concord Biotech IPO | Quadria Capital-backed Helix will be exiting the company by selling entire shareholding via IPO. Hence, the company will not get any money from the offer. Concord Biotech IPO | Quadria Capital-backed Helix will be exiting the company by selling entire shareholding via IPO. Hence, the company will not get any money from the offer.  Moneycontrol Latest News Read More  

Leave a Reply

Your email address will not be published. Required fields are marked *

en_USEnglish